Politician trade (Senate)

Medtronic (MDT): Sen. John P Ricketts disclosed a sale $50K–$100K

Sen. John P Ricketts disclosed a sale of Medtronic in the $50K–$100K range.

$50,001–$100,000
Reported range · official band, not an exact amount
29 days
Disclosure lag
Traded
Sep 21, 2023
Disclosed
Oct 20, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. Sep 21, 2023 · this disclosureCongressDisclosed sale of MDT — reported range $50,001 - $100,000

What came next

  1. Sep 26, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. Oct 24, 2023CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  3. Nov 16, 2023FDARecall: AbsorbaTack Absorbable Fixation Device 30 Violet Absorbable Tacks 5 mm- -intended for fixation of prosthetic material to soft tissue in minimally invasive and…
  4. Nov 17, 2023FDAFDA device approval: Symplicity Spyral™ Renal Denervation System
  5. Nov 20, 2023FDARecall: Protege GPS Self-Expanding Peripheral Stent System, product number SERB65-09-60-80, Sterile.
  6. Nov 28, 2023FDARecall: Medtronic, REF 9733235, Pin, 100mm, STERILE, PERCUTANEOUS
  7. Nov 28, 2023FDARecall: Medtronic, REF 9733236, Pin, 150mm, STERILE, PERCUTANEOUS
  8. Dec 2, 2023FDAFDA device clearance: Cosine-10TM Diagnostic Catheter
  9. Dec 5, 2023CongressDisclosed purchase of MDT — reported range $15,001 - $50,000
  10. Dec 6, 2023FDAFDA device clearance: LINQ II Insertable Cardiac Monitor
  11. Dec 7, 2023FDAFDA device clearance: DLP Silicone Coronary Artery Ostial Cannulae
  12. Dec 7, 2023FDARecall: Cobalt XT DR MRI SureScan Implantable Cardioverter Defibrillator, product number DDPA2D1
  13. Dec 12, 2023Congress · 1 personMembers of Congress: 3 sales
  14. Dec 13, 2023FDAFDA device approval: PulseSelect™ Pulsed Field Ablation (PFA) system
  15. Dec 19, 2023FDARecall: Model A710 Intellis Clinician Programmer Application, version 2.0.97
  16. Dec 21, 2023FDARecall: Surgilon Braided Nylon sutures: 88861919-31 SURGILON* 4-0 BLK 7X75CMPCT 88861919-41 SURGILON* 3-0 BLK 7X75CMPCT 88861919-51 SURGILON* 2-0 BLK 7X75CMPCT 8886191…
  17. Dec 21, 2023FDARecall: Sofsilk Braided Silk sutures: CS-211 SOFSILK* 4-0 BLK 45CM CVF21 X36 GS-831 SOFSILK* 4-0 BLK 75CM V20 X36 S-176 SOFSILK* 0 BLK 12X45CM PCT X24 S-182 SOFSILK* 5…
  18. Jan 9, 2024FDARecall: Medtronic Invos, Reusable Infant Sensor Adapter Cable for PM7100, REF: PMAC71RIC
  19. Jan 9, 2024FDARecall: Medtronic Invos, Reusable Sensor Cable for PM7100, REF: PMAC71RSC
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Sen. John P Ricketts

The full history of Sen. John P Ricketts is on the profile page.

How this filing works

Explore the data

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data